Medistim ASA (OSL:MEDI)
Norway · Delayed Price · Currency is NOK 218.00
-3.00 (-1.36%)
Aug 11, 2025, 4:25 PM CET
Ligand Pharmaceuticals Market Cap
Medistim ASA has a market cap or net worth of 4.04 billion as of August 11, 2025. Its market cap has increased by 29.64% in one year.
Market Cap
4.04B
Enterprise Value
3.88B
Revenue
603.92M
Ranking
n/a
PE Ratio
32.94
Stock Price
$218.00
Market Cap Chart
Since May 28, 2004, Medistim ASA's market cap has increased from 40.53M to 4.04B, an increase of 9,859.24%. That is a compound annual growth rate of 24.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 4.04B | 47.41% |
| Dec 30, 2024 | 2.74B | -30.01% |
| Dec 29, 2023 | 3.91B | -7.22% |
| Dec 30, 2022 | 4.22B | -37.01% |
| Dec 30, 2021 | 6.69B | 47.10% |
| Dec 30, 2020 | 4.55B | 30.29% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 2.96B |
| Photocure ASA | 1.62B |
| Vistin Pharma ASA | 1.09B |
| Omda AS | 1.02B |
| ArcticZymes Technologies ASA | 978.02M |
| Gentian Diagnostics ASA | 866.74M |
| Thor Medical ASA | 840.11M |
| Lytix Biopharma AS | 640.30M |